Gene · 2532
Papers3,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial. | Schizophr Res | 2024 | 37633776 | PubTator, text mining | PubMed |
| In vitro and silico studies of geraniin interfering with HSV-2 replication by targeting glycoprotein D. | Nat Prod Res | 2024 | 37585693 | PubTator, text mining | PubMed |
| A Multimodal Omics Framework to Empower Target Discovery for Cardiovascular Regeneration. | Cardiovasc Drugs Ther | 2024 | 37421484 | PubTator, text mining | PubMed |
| The Molecular Phenotype of Kidney Transplants: Insights From the MMDx Project. | Transplantation | 2024 | 37310258 | PubTator, text mining | PubMed |
| Identification of Key Genes in Angiogenesis of Breast and Prostate Cancers in the Context of Different Cell Types. | Curr Med Chem | 2024 | 36999716 | PubTator, text mining | PubMed |
| Recent advances in understanding the human host immune response in tuberculous meningitis. | Front Immunol | 2023 | 38264653 | PubTator, text mining | PubMed |
| Innovations in monoclonal antibody-based multipurpose prevention technology (MPT) for the prevention of sexually transmitted infections and unintended pregnancy. | Front Reprod Health | 2023 | 38264184 | PubTator, text mining | PubMed |
| Rapid and accurate detection of herpes simplex virus type 2 using a low-cost electrochemical biosensor. | Cell Rep Phys Sci | 2023 | 38239491 | PubTator, text mining | PubMed |
| Molecular Characteristics and Pathogenicity of Staphylococcus aureus Exotoxins. | Int J Mol Sci | 2023 | 38203566 | PubTator, text mining | PubMed |
| A ten long noncoding RNA-based prognostic risk model construction and mechanism study in the basal-like immune-suppressed subtype of triple-negative breast cancer. | Transl Cancer Res | 2023 | 38193005 | PubTator, text mining | PubMed |
| Key Cell Types and Biomarkers in Heart Failure Identified through Analysis of Single-Cell and Bulk RNA Sequencing Data. | Mediators Inflamm | 2023 | 38169915 | PubTator, text mining | PubMed |
| Transcriptome studies of congenital heart diseases: identifying current gaps and therapeutic frontiers. | Front Genet | 2023 | 38152655 | PubTator, text mining | PubMed |
| Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer. | Pharmgenomics Pers Med | 2023 | 38152411 | PubTator, text mining | PubMed |
| The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas. | Clin Transl Med | 2023 | 38148640 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis of lung cells in COVID-19 patients with diabetes, hypertension, and comorbid diabetes-hypertension. | Front Endocrinol (Lausanne) | 2023 | 38144556 | PubTator, text mining | PubMed |
| Flavonoids with Anti-Herpes Simplex Virus Properties: Deciphering Their Mechanisms in Disrupting the Viral Life Cycle. | Viruses | 2023 | 38140581 | PubTator, text mining | PubMed |
| Challenges and Opportunities in the Process Development of Chimeric Vaccines. | Vaccines (Basel) | 2023 | 38140232 | PubTator, text mining | PubMed |
| Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells. | Vaccines (Basel) | 2023 | 38140209 | PubTator, text mining | PubMed |
| Immunogenicity and Therapeutic Efficacy of a Sendai-Virus-Vectored HSV-2 Vaccine in Mouse and Guinea Pig Models. | Vaccines (Basel) | 2023 | 38140157 | PubTator, text mining | PubMed |
| Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. | Int J Mol Sci | 2023 | 38139427 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2532/papers?page=12